Advertisement
Screener

ARMATA PHARMACEUTICALS, INC. (ARMP) Increase (Decrease) in Prepaid Expense and Other Assets

ARMATA PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

ARMATA PHARMACEUTICALS, INC. (ARMP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12

  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.01M, a 17.58% increase year-over-year.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$948.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$194.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.02M, a 318.45% decline year-over-year.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$39.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$5.11M.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$4.83M, a 162.99% decline from fiscal 2022.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $7.66M, a 292.92% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$2.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.06M
10-Q · filed 2026-08-12
$871.00K
derived: sum of 3 quarters · filed 2026-08-12
-$147.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$948.00K
10-Q · filed 2026-05-13
-$1.14M
derived: sum of 2 quarters · filed 2026-05-13
-$2.16M
derived: sum of 3 quarters · filed 2026-05-13
-$448.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$194.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$1.21M
derived: sum of 2 quarters · filed 2026-03-25
$500.00K
derived: sum of 3 quarters · filed 2026-08-12
-$39.00K
10-K · filed 2026-03-25
2025-09-30-$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$694.00K
derived: sum of 2 quarters · filed 2026-08-12
$155.00K
10-Q · filed 2025-11-12
-$2.86M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$1.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.17M
10-Q · filed 2026-08-12
-$1.84M
derived: sum of 3 quarters · filed 2026-08-12
-$1.37M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$539.00K
10-Q · filed 2026-05-13
-$3.55M
derived: sum of 2 quarters · filed 2026-05-13
-$3.08M
derived: sum of 3 quarters · filed 2026-05-13
-$3.85M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$2.54M
derived: sum of 2 quarters · filed 2026-03-25
-$3.31M
derived: sum of 3 quarters · filed 2026-03-25
-$5.11M
10-K · filed 2026-03-25
2024-09-30$466.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$298.00K
derived: sum of 2 quarters · filed 2025-11-12
-$2.10M
10-Q · filed 2025-11-12
-$6.99M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$764.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$2.56M
10-Q · filed 2025-08-12
-$7.46M
derived: sum of 3 quarters · filed 2025-08-12
-$9.59M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$1.80M
10-Q · filed 2025-05-14
-$6.70M
derived: sum of 2 quarters · filed 2025-05-14
-$8.83M
derived: sum of 3 quarters · filed 2025-05-14
-$8.04M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
-$7.03M
derived: sum of 2 quarters · filed 2025-03-21
-$6.24M
derived: sum of 3 quarters · filed 2025-03-21
-$4.83M
10-K · filed 2025-03-21
2023-09-30-$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$1.35M
derived: sum of 2 quarters · filed 2024-11-13
$72.00K
10-Q · filed 2024-11-13
$5.38M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$789.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$2.21M
10-Q · filed 2024-08-13
$7.51M
derived: sum of 3 quarters · filed 2024-08-13
$10.31M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.42M
10-Q · filed 2024-05-07
$2.10M
10-Q · filed 2023-05-11
$6.73M
derived: sum of 2 quarters · filed 2024-05-07
$9.52M
derived: sum of 3 quarters · filed 2024-05-07
$9.80M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$5.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$8.10M
derived: sum of 2 quarters · filed 2024-03-21
$8.38M
derived: sum of 3 quarters · filed 2024-03-21
$7.66M
10-K · filed 2024-03-21
$8.71M
10-K · filed 2023-03-16
2022-09-30$2.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$3.08M
derived: sum of 2 quarters · filed 2023-11-14
$2.35M
10-Q · filed 2023-11-14
$3.48M
10-Q · filed 2022-11-09
$4.07M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$284.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$439.00K
10-Q · filed 2023-08-14
$667.00K
10-Q · filed 2022-08-11
$1.27M
derived: sum of 3 quarters · filed 2023-08-14
$1.14M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$723.00K
10-Q · filed 2023-05-11
$990.00K
derived: sum of 2 quarters · filed 2023-05-11
$858.00K
derived: sum of 3 quarters · filed 2023-05-11
$1.24M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$1.58M
derived: sum of 2 quarters · filed 2023-03-16
$1.97M
derived: sum of 3 quarters · filed 2023-03-16
$1.95M
10-K · filed 2023-03-16
2021-09-30-$132.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$252.00K
derived: sum of 2 quarters · filed 2022-11-09
$237.00K
10-Q · filed 2022-11-09
$69.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$384.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$369.00K
10-Q · filed 2022-08-11
$201.00K
derived: sum of 3 quarters · filed 2022-08-11
$208.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$15.00K
10-Q · filed 2022-05-12
-$183.00K
derived: sum of 2 quarters · filed 2022-05-12
-$176.00K
derived: sum of 3 quarters · filed 2022-05-12
$899.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$161.00K
derived: sum of 2 quarters · filed 2022-03-17
$914.00K
derived: sum of 3 quarters · filed 2022-03-17
$994.00K
10-K · filed 2022-03-17
2020-09-30$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$1.08M
derived: sum of 2 quarters · filed 2021-11-10
$1.16M
10-Q · filed 2021-11-10
$1.01M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$1.16M
10-Q · filed 2021-08-12
$1.01M
derived: sum of 3 quarters · filed 2021-08-12
$750.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$80.00K
10-Q · filed 2021-05-13
-$69.00K
derived: sum of 2 quarters · filed 2021-05-13
-$325.00K
derived: sum of 3 quarters · filed 2021-05-13
-$27.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$149.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$405.00K
derived: sum of 2 quarters · filed 2021-03-18
-$107.00K
derived: sum of 3 quarters · filed 2021-03-18
-$348.00K
10-K · filed 2021-03-18
2019-09-30-$256.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$42.00K
derived: sum of 2 quarters · filed 2020-11-12
-$199.00K
10-Q · filed 2020-11-12
$181.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$298.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$57.00K
10-Q · filed 2020-08-13
$437.00K
derived: sum of 3 quarters · filed 2020-08-13
$483.00K
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$241.00K
10-Q · filed 2020-05-14
$156.00K
10-Q · filed 2019-05-06
$139.00K
derived: sum of 2 quarters · filed 2020-05-14
$185.00K
derived: sum of 3 quarters · filed 2020-05-14
-$188.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$380.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
$426.00K
derived: sum of 2 quarters · filed 2020-03-19
$53.00K
derived: sum of 3 quarters · filed 2020-03-19
$337.00K
10-K · filed 2020-03-19
-$2.00K
10-K · filed 2019-03-25
2018-09-30$46.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$327.00K
derived: sum of 2 quarters · filed 2019-11-12
-$43.00K
10-Q · filed 2019-11-12
$85.00K
10-Q · filed 2018-11-08
-$54.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$373.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$89.00K
10-Q · filed 2019-08-14
$69.00K
10-Q · filed 2018-08-09
-$100.00K
derived: sum of 3 quarters · filed 2019-08-14
-$118.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$284.00K
10-Q · filed 2019-05-06
$273.00K
derived: sum of 2 quarters · filed 2019-05-06
$255.00K
derived: sum of 3 quarters · filed 2019-05-06
$221.00K
derived: sum of 4 quarters · filed 2019-05-06
2017-12-31-$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
-$29.00K
derived: sum of 2 quarters · filed 2019-03-25
-$63.00K
derived: sum of 3 quarters · filed 2019-03-25
-$381.00K
10-K · filed 2019-03-25
2017-09-30-$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$52.00K
derived: sum of 2 quarters · filed 2018-11-08
-$370.00K
10-Q · filed 2018-11-08
-$358.00K
10-Q · filed 2017-11-14
-$666.00K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$34.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$352.00K
10-Q · filed 2018-08-09
-$340.00K
10-Q · filed 2017-08-14
-$648.00K
derived: sum of 3 quarters · filed 2018-08-09
-$654.00K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$318.00K
10-Q · filed 2018-05-15
-$308.00K
10-Q · filed 2017-05-15
-$614.00K
derived: sum of 2 quarters · filed 2018-05-15
-$620.00K
derived: sum of 3 quarters · filed 2018-05-15
-$610.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$296.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$302.00K
derived: sum of 2 quarters · filed 2018-03-14
-$292.00K
derived: sum of 3 quarters · filed 2018-03-14
-$247.00K
10-K · filed 2018-03-14
-$105.00K
10-K · filed 2017-03-27
2016-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$4.00K
derived: sum of 2 quarters · filed 2017-11-14
$49.00K
10-Q · filed 2017-11-14
-$215.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$55.00K
10-Q · filed 2017-08-14
-$209.00K
derived: sum of 3 quarters · filed 2017-08-14
$63.00K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$45.00K
10-Q · filed 2017-05-15
-$219.00K
derived: sum of 2 quarters · filed 2017-05-15
$53.00K
derived: sum of 3 quarters · filed 2017-05-15
$153.00K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$264.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$8.00K
derived: sum of 2 quarters · filed 2017-03-27
$108.00K
derived: sum of 3 quarters · filed 2017-03-27
$182.00K
10-K · filed 2017-03-27
2015-09-30$272.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$372.00K
derived: sum of 2 quarters · filed 2016-11-10
$446.00K
10-Q · filed 2016-11-10
$337.00K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$174.00K
10-Q · filed 2016-08-15
$65.00K
derived: sum of 3 quarters · filed 2016-08-15
-$13.00K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$74.00K
10-Q · filed 2016-05-12
-$35.00K
derived: sum of 2 quarters · filed 2016-05-12
-$113.00K
derived: sum of 3 quarters · filed 2016-05-12
$68.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$109.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$187.00K
derived: sum of 2 quarters · filed 2016-03-30
-$6.00K
derived: sum of 3 quarters · filed 2016-03-30
$42.00K
10-K · filed 2016-03-30
2014-09-30-$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$103.00K
derived: sum of 2 quarters · filed 2015-11-16
$151.00K
10-Q · filed 2015-11-16
$108.00K
10-Q · filed 2014-11-14
$147.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$181.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$229.00K
10-Q · filed 2015-08-13
$126.00K
10-Q · filed 2014-09-12
$225.00K
derived: sum of 3 quarters · filed 2015-08-13
$291.00K
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31$48.00K
10-Q · filed 2015-05-15
$109.00K
10-Q · filed 2014-05-20
$44.00K
derived: sum of 2 quarters · filed 2015-05-15
$110.00K
derived: sum of 3 quarters · filed 2015-05-15
-$22.00K
derived: sum of 4 quarters · filed 2015-05-15
2013-12-31-$4.00K
derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15
$62.00K
derived: sum of 2 quarters · filed 2015-04-15
-$70.00K
derived: sum of 3 quarters · filed 2015-04-15
$149.00K
10-Q/A · filed 2015-04-15
$23.00K
10-Q · filed 2014-05-20
2013-09-30$66.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15
-$66.00K
derived: sum of 2 quarters · filed 2015-04-15
$153.00K
10-Q/A · filed 2015-04-15
2013-06-30-$132.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15
$87.00K
10-Q/A · filed 2015-04-15
2013-03-31$219.00K
10-Q/A · filed 2015-04-15
$222.00K
10-Q · filed 2014-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22